These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3566998)

  • 1. Neostigmine in the antagonism of the action of atracurium.
    Fox MA; Keens SJ; Utting JE
    Br J Anaesth; 1987 Apr; 59(4):468-72. PubMed ID: 3566998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonism of atracurium-induced neuromuscular blockade by neostigmine or edrophonium.
    Astley BA; Hughes R; Payne JP
    Br J Anaesth; 1986 Nov; 58(11):1290-5. PubMed ID: 3778793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonism of blockade produced by atracurium or vecuronium with low doses of neostigmine.
    Jones JE; Parker CJ; Hunter JM
    Br J Anaesth; 1988 Nov; 61(5):560-4. PubMed ID: 2905146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimum dose of neostigmine at two levels of atracurium-induced neuromuscular block.
    Harper NJ; Wallace M; Hall IA
    Br J Anaesth; 1994 Jan; 72(1):82-5. PubMed ID: 8110558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neostigmine and edrophonium as antagonists of atracurium and pancuronium.
    Sanfilippo M; Vilardi V; Fierro G; Rosa G; Pelaia P; Gasparetto A
    Acta Anaesthesiol Scand; 1988 Aug; 32(6):437-40. PubMed ID: 2845694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of edrophonium and neostigmine for the antagonism of atracurium-induced neuromuscular block.
    Lavery GG; Mirakhur RK; Gibson FM
    Anesth Analg; 1985 Sep; 64(9):867-70. PubMed ID: 3161421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accelerated reversal of atracurium blockade with divided doses of neostigmine.
    Abdulatif M; Naguib M
    Can Anaesth Soc J; 1986 Nov; 33(6):723-8. PubMed ID: 3779494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of intense neuromuscular blockade following infusion of atracurium.
    Engbaek J; Ostergaard D; Skovgaard LT; Viby-Mogensen J
    Anesthesiology; 1990 May; 72(5):803-6. PubMed ID: 2160206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evoked electromyographic and mechanical responses of the adductor pollicis compared during the onset of neuromuscular blockade by atracurium or alcuronium, and during antagonism by neostigmine.
    Harper NJ; Bradshaw EG; Healy TE
    Br J Anaesth; 1986 Nov; 58(11):1278-84. PubMed ID: 3778792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonism of vecuronium and atracurium: comparison of neostigmine and edrophonium administered at 5% twitch height recovery.
    Caldwell JE; Robertson EN; Baird WL
    Br J Anaesth; 1987 Apr; 59(4):478-81. PubMed ID: 2882769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonism of low degrees of atracurium-induced neuromuscular blockade: dose-effect relationship for neostigmine.
    Fuchs-Buder T; Meistelman C; Alla F; Grandjean A; Wuthrich Y; Donati F
    Anesthesiology; 2010 Jan; 112(1):34-40. PubMed ID: 19952724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonism of intense atracurium-induced neuromuscular block in children.
    Gwinnutt CL; Walker RW; Meakin G
    Br J Anaesth; 1991 Jul; 67(1):13-6. PubMed ID: 1859751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-response relationships for edrophonium and neostigmine antagonism of atracurium and cisatracurium-induced neuromuscular block.
    Naguib M; Riad W
    Can J Anaesth; 2000 Nov; 47(11):1074-81. PubMed ID: 11097536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonism of profound neuromuscular blockade induced by vecuronium or atracurium. Comparison of neostigmine with edrophonium.
    Caldwell JE; Robertson EN; Baird WL
    Br J Anaesth; 1986 Nov; 58(11):1285-9. PubMed ID: 2877681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recovery characteristics following antagonism of atracurium with neostigmine or edrophonium.
    Jones RM; Pearce AC; Williams JP
    Br J Anaesth; 1984 May; 56(5):453-7. PubMed ID: 6326785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-response relationships for edrophonium and neostigmine as antagonists of moderate and profound atracurium blockade.
    Donati F; Smith CE; Bevan DR
    Anesth Analg; 1989 Jan; 68(1):13-9. PubMed ID: 2910133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recovery of neuromuscular function after atracurium and pancuronium maintenance of pancuronium block.
    Whalley DG; Lewis B; Bedocs NM
    Can J Anaesth; 1994 Jan; 41(1):31-5. PubMed ID: 8111941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonism of atracurium with neostigmine. Effect of dose on speed of recovery.
    Goldhill DR; Carter JA; Suresh D; Whitehead JP; Flynn PJ
    Anaesthesia; 1991 Jun; 46(6):496-9. PubMed ID: 2048675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Priming reversal of profound atracurium blockade by edrophonium and neostigmine.
    Liu CH; Lin IS; Liu CG; Peng TH; Yeh YJ; Chuu LJ; Lin SY
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1995 May; 11(5):257-64. PubMed ID: 7602663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimum time for neostigmine reversal of atracurium-induced neuromuscular blockade.
    Kirkegaard-Nielsen H; Helbo-Hansen HS; Lindholm P; Severinsen IK; Pedersen HS; Jensen EW
    Can J Anaesth; 1996 Sep; 43(9):932-8. PubMed ID: 8874911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.